title: The influence of growth hormone (rhGH) therapy on tooth formation in idiopathic short statured children.
abstract: The purpose of this preliminary study was to evaluate tooth formation in children with idiopathic short stature, before and during treatment with recombinant growth hormone (rhGH). Twenty-nine short-statured children ages 6 to 13 years were assigned into two treatment groups, an "experimental" group (n = 18), which received rhGH, and a "control" group (n = 11), which was observed for 1 year before commencing rhGH treatment. Clinical and radiographic records were obtained at the initial, year 1, and year 2 visits. Tooth formation and stature were assessed by calculating Z-scores, appropriate for the age and gender of each child. Delta-Z scores, which measure the change in Z-score over time, were also calculated between annual visits. Height was measured and recorded every 3 months, and Z-score statural norms for age and gender were derived from the 1977 National Center for Health Services national probability sampling. Tooth formation standards were derived from Moorrees et al. A matched control sample for tooth development was derived from untreated children. Tooth formation was initially delayed although the degree of reduction in stature exceeded the initial degree of delay in tooth formation. During this 2-year study, rhGH therapy had a significant influence on acceleration or gain in stature, but did not have a significant influence on tooth formation.
authors: University of Michigan, Ann Arbor.
authors: R K
authors: RK
authors: Ito
authors: K W
authors: KW
authors: Vig
authors: S M
authors: SM
authors: Garn
authors: N J
authors: NJ
authors: Hopwood
authors: P J
authors: PJ
authors: Loos
authors: P M
authors: PM
authors: Spalding
authors: B S
authors: BS
authors: Deputy
authors: B C
authors: BC
authors: Hoard
mesh_terms: D000293:Adolescent; D000365:Age Determination by Skeleton; D001827:Body Height / Q000187:drug effects; D002648:Child; D004392:Dwarfism / Q000188:drug therapy* / Q000503:physiopathology*; D005260:Female; D006130:Growth Disorders / Q000188:drug therapy; D013006:Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009805:Odontogenesis / Q000187:drug effects*; D011446:Prospective Studies; D015203:Reproducibility of Results; D014074:Tooth Calcification / Q000187:drug effects; D014092:Tooth Root / Q000187:drug effects / Q000502:physiology
chemical_list: D013006:Growth Hormone